NCT05868772

Brief Summary

The objective is to assess the efficiency of the Active Sentry handpiece at low intraocular pressure (IOP) compared with the Ozil at high IOP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 3, 2023

Completed
13 days until next milestone

Study Start

First participant enrolled

May 16, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 22, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 19, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 19, 2024

Completed
12 months until next milestone

Results Posted

Study results publicly available

April 17, 2025

Completed
Last Updated

April 17, 2025

Status Verified

April 1, 2025

Enrollment Period

11 months

First QC Date

May 3, 2023

Results QC Date

March 4, 2025

Last Update Submit

April 16, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total Aspiration Time

    Day of surgery (Day 0)

Secondary Outcomes (3)

  • Total Fluid Volume

    Day of surgery (Day 0)

  • Total Phaco Time

    Day of surgery (Day 0)

  • Central Corneal Thickness

    1 week postoperative

Other Outcomes (1)

  • Cumulative Dissipated Energy (CDE)

    Day of surgery (Day 0)

Study Arms (2)

Active Sentry Handpiece

At low IOP settings

Device: Active Sentry Handpiece

Ozil Handpiece

At high IOP settings

Device: Ozil Handpiece

Interventions

With low IOP settings

Active Sentry Handpiece

With high IOP settings.

Ozil Handpiece

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Eligible test subjects will be 50 years of age or older and who are eligible to undergo sequential bilateral uncomplicated cataract surgery.

You may qualify if:

  • Subjects are eligible for the study if they meet the following criteria:
  • Note: Ocular criteria must be met in both eyes.
  • Be eligible to undergo sequential bilateral uncomplicated cataract surgery.
  • Undergo uneventful cataract surgery.
  • Gender: Males and Females.
  • Both eyes must have same grade of cataract.
  • Willing and able to provide written informed consent for participation in the study.
  • Willing and able to comply with scheduled visits and other study procedures.

You may not qualify if:

  • Patient under 50 years of age.
  • Unable to complete sequential bilateral cataract surgery in both eyes by the same surgeon (JS).
  • Patient cataract surgery complicated by posterior capsular tear.
  • Any disease state deemed by PI that increases risk of complicated cataract surgery (ie Pseudoexfoliation syndrome, zonular dehiscence, history of eye trauma, RA, prior refractive surgery, etc).
  • The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial.
  • Pregnancy has a known effect on the stability of refractions and visual acuity. As such, subjects who become pregnant during the study will not be discontinued but their data may be excluded from analyses of effectiveness.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cataract & Laser Institute

Medford, Oregon, 97504, United States

Location

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Results Point of Contact

Title
Dr Justin Spaulding
Organization
Cataract & Laser Institute

Study Officials

  • Justin Spaulding, DO

    Cataract and Laser Institute

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 3, 2023

First Posted

May 22, 2023

Study Start

May 16, 2023

Primary Completion

April 19, 2024

Study Completion

April 19, 2024

Last Updated

April 17, 2025

Results First Posted

April 17, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations